Kraj: Izrael
Język: hebrajski
Źródło: Ministry of Health
OFATUMUMAB 20 MG/ML
GLAXO SMITH KLINE (ISRAEL) LTD
L01XC10
CONCENTRATE FOR SOLUTION FOR INFUSION
I.V
GLAXO OPERATIONS (UK) LIMITED
OFATUMUMAB
Treatment of chronic lymphocytic leukaemia (CLL) in patients who are refractory to fludarabine and alemtuzumab
2012-10-01